Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

UCD Researchers Reveal Six New Genome Sequences And Fundamental Insights To The Candida Fungus Family
An international research collaboration coordinated by UCD researchers and involving scientists at 21 institutes including the genome sequencing centres in the Wellcome Trust Sanger Institute, UK and the Broad Institute at MIT and Harvard, USA have defined six new genome sequences in the Candida fungus family and identified genetic differences in species that cause disease.
generic viagra online
Animal TB "Tracker" To Speed Drug And Vaccine Studies
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
News of the day
HHS Rescinds Controversial Medicaid Regulations
The Health and Human Services Department Monday "rescinded three controversial Bush administration regulations governing Medicaid and said it would postpone and possibly change or rescind a fourth," according to CQ Politics.
Mental Health

Proceedings Of NIAID Workshop On Immunity To Malaria Published

Researchers have made progress in developing malaria vaccines over the past few decades, but the goal remains a daunting challenge. Malaria has evolved to thwart almost every aspect of the human immune system. On March 16-17, 2009, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, convened a workshop to encourage more immunologists to enter malaria research and to foster scientific collaborations that may help lead to the development of effective malaria vaccines. The proceedings of that meeting are in the July 2009 issue of Nature Immunology, and available online June 18. Nearly half of the world"s population, or about 3.3 billion people, are at risk of malarial infection, and it causes more than 250 million clinical episodes and one million deaths each year. Anyone can get malaria but pregnant women, young children, and first-time suffers often have more complicated infections. Unlike diseases such as chickenpox and measles, where a single infection offers life-long immunity, bouts of malaria can occur repeatedly. Individuals acquire malaria through the bite of Anopheles mosquitoes infected with any of four species of Plasmodium parasites. To develop a protective malaria vaccine, researchers must identify which of the Plasmodium parasite"s 5,300 proteins provoke a strong immune response. Further complicating vaccine development, the parasite makes different proteins at each stage of its lifecycle. NIAID recognizes that collaboration among scientists of diverse disciplines is necessary to accelerate research in malaria. The goals of the NIAID-supported workshop were to identify research gaps in malaria immunology; address issues that hinder immunologists from conducting malaria research; identify res to facilitate studies of immunity in malaria; and challenge immunologists to join with their colleagues in unraveling the immune mechanisms that protect against or contribute to the development and effects of malarial disease. NIAID is the lead U.S. government agency that supports basic biomedical and clinical research in malaria. The NIAID Malaria Research Agenda and Strategic Plan, both published in April 2008, emphasize the need for improved understanding of host immune responses to malaria parasite infection and the relationship between immune responses and disease pathogenesis. ARTICLE: AD Augustine, et al. NIAID Workshop on Immunity to Malaria: Addressing Immunological Challenges. Nature Immunology DOI:10.1038/ni0709-673 (2009). WHO: Anthony S. Fauci, M.D., Director of NIAID; or Alison Deckhut Augustine, Ph.D., Chief, Immunoregulation Section, Basic Immunology Branch, NIAID Linda Perrett NIH/National Institute of Allergy and Infectious Diseases


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009